Shield Bio

Bringing 3rd generation, nanopore sequencing to healthcare to solve…

Based based in San Jose, CA, USA, Shield Bio works in healthcare.

Profile

Shield Bio is a precision medicine company with a
proprietary platform that enables reliable nanopore
sequencing in under a minute, in a clinical setting. It is
focused on bringing 3rd generation or "nanopore"
sequencing into clinical use to deliver on the promise of
precision medicine. Shield is initially using the technology to
improve the treatment of infectious disease and address the
unmet clinical need of sepsis, which kills 300,000 people a
year in the US alone.

Its activity falls under healthcare; the profile below is assembled from public directory data.

The company is recorded as being based in San Jose, CA, USA.

The company is listed at the Summer 2016 stage of development.

The company reports a headcount in the 28 range.

Website: shieldbio.com